Survey Finds Mesh Use Dropped for POP Repair
Diminished use of transvaginal mesh in Pelvic Organ Prolapse (POP) repair suggests that surgeons appear to be heeding warnings about the medical device issued by the Food and Drug Administration (FDA), revealed a recent survey.
Renal and Urology News reported that the study found surgeon practice patterns changed after July 2011, which is when the FDA warned specialists and generalists on the usage of mesh for recurrent vaginal POP.
To verify the impact of the FDA warning, surgeons were surveyed in November 2011. The researchers presented the survey at the 33rd Annual Scientific Meeting of the American Urogynecologic Society.
The results indicated decreased mesh use for recurrent vaginal POP repair. Surgeons were more likely to avoid mesh to treat recurrent POP, reports Renal and Urology News.
The survey indicated that 23 percent of surgeons intended to reduce their use of mesh and 53.7 percent reported changing their patient counseling methods to include more mesh-specific information. Transvaginal meshes are implantable medical devices for the treatment of pelvic organ prolapse and incontinence. They are associated with cause painful and dangerous side effects such as bleeding, erosion, urinary problems and painful sexual intercourse. If you or a loved one has been harmed by an unsafe medical product, contact Sokolove Law for a free legal consultation and to find out if a product liability lawyer may be able to help you.